Atlas Trials

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

Clinical trial NCT00216086 · TERMINATED

Trial details

NCT number
NCT00216086
Sponsor
Gabi Chiorean, MD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2005-05-01
Primary completion
2008-05-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.